Analysis of the Genotype/Phenotype Relationship in the Fuchs' Corneal Endothelial Dystrophy in France
This research is investigating Fuchs' corneal dystrophy, a common eye condition that affects the clear front part of your eye (the cornea). Scientists are trying to understand why some people have different forms of the condition. They'll be looking closely at information from patients, examining eye tissue under a microscope, and checking for specific genetic changes. By comparing these different aspects – what doctors see, what the tissue looks like, and a person's genes – they aim to gain a clearer picture of how Fuchs' dystrophy develops. This could help doctors better manage the condition in the future.
At a glance
What is this study about?
This study is about a common eye condition called Fuchs' corneal dystrophy. This condition affects your cornea, which is the clear, dome-shaped front surface of your eye. In Fuchs' dystrophy, cells that line the back of your cornea don't work as well as they should, which can cause your vision to become cloudy or blurry.
Researchers already know that there are different ways Fuchs' dystrophy can show up in people, and they've also noticed variations when looking at eye tissue very closely under a microscope. We also know that certain changes in our genes can play a role in developing this condition. This study wants to bring all this information together.
By carefully looking at the signs of Fuchs' dystrophy in patients, examining their eye tissue, and also checking their genes, the researchers hope to find connections. They want to understand how these different pieces of the puzzle – what the doctor sees, what the tissue looks like, and a person's genetic makeup – influence each other and contribute to how Fuchs' dystrophy develops. This deeper understanding could eventually help doctors provide better care for people with this condition.
Key takeaways
- Studies Fuchs' corneal dystrophy, a common eye condition.
- Aims to link patient symptoms, microscopic tissue changes, and genes.
- Hopes to improve understanding of how Fuchs' dystrophy develops.
- Participation requires a confirmed diagnosis and planned corneal surgery.
- Primarily involves sharing existing medical information and tissue samples.
- Does not involve new treatments or medications.
Who may be eligible?
To join this study, you need to be an adult, aged 18 or older. You must also be signed up to a social security scheme or have the right to use one, which is standard for most people in the UK.
Crucially, you must have been diagnosed with Fuchs' corneal dystrophy by an eye specialist looking at your eye with a special magnifying light (called a slit lamp). You also need to be planning to have an eye operation called an endothelial keratoplasty, which is a type of corneal transplant.
People who are under guardianship or curatorship (meaning someone else legally manages their affairs) cannot take part in this study. Otherwise, both men and women are welcome to join if they meet the other requirements.
Could this study suit you?
Answer these quick questions to see if you may be eligible. This is a guide only — the research team makes the final call.
- Are you 18 years old or older?
- Do you have a diagnosis of Fuchs' corneal dystrophy from an eye doctor?
- Are you scheduled to have an endothelial keratoplasty (corneal transplant)?
- Are you able to provide consent to take part in the study?
- Are you not under guardianship or curatorship?
What does participation involve?
If you decide to take part in this study, you would first need to sign a consent form, showing you understand what's involved and agree to participate. The researchers will then collect some information about your eye condition and your health. They will also look at samples of your eye tissue, which would likely come from the corneal transplant you are already having. They will also collect a sample (like blood or saliva) for genetic testing to look for specific gene changes. The study involves a one-off collection of information and samples, typically associated with your planned surgery, rather than requiring additional visits or medication. The total time you would be actively involved in the study itself is minimal, as it primarily involves the collection of pre-existing medical information and samples during your scheduled care.
Potential risks and benefits
Locations (1)
- CHU Saint-EtienneVerified postcodeSaint-Etienne, France· Recruiting
Common questions
What is Fuchs' corneal dystrophy?
It's an eye condition where the cells in the clear front part of your eye (cornea) don't work properly, which can make your vision cloudy.
What does 'genotyping' mean?
Genotyping means looking at your genes to see if there are any specific variations that might be linked to your eye condition.
Will this study cure my Fuchs' dystrophy?
No, this study is for research to learn more about the condition, not a treatment. It won't directly cure your Fuchs' dystrophy.
Do I have to take new medication?
No, this study does not involve taking any new or experimental medications.
Will my information be kept private?
Yes, all your personal and medical information will be kept confidential and used only for the study's research purposes.
How to find out more
GILLES THURET, MD-PhD
Always speak to your GP or specialist before deciding to take part in a study.
Interested in taking part?
Discussion
Community discussion
Powered by our forum at community.patient.info. Please be respectful — this is not medical advice.